Structure-Based Design of Inhibitors Selective for Human Proteasome beta 2c or beta 2i Subunits.
Xin, B.T., Huber, E.M., de Bruin, G., Heinemeyer, W., Maurits, E., Espinal, C., Du, Y., Janssens, M., Weyburne, E.S., Kisselev, A.F., Florea, B.I., Driessen, C., van der Marel, G.A., Groll, M., Overkleeft, H.S.(2019) J Med Chem 62: 1626-1642
- PubMed: 30657666 
- DOI: 10.1021/acs.jmedchem.8b01884
- Primary Citation of Related Structures:  
6HUB, 6HTR, 6HTP, 6HTC, 6HTB, 6HTD, 6HVA, 6HV5, 6HV4, 6HUV - PubMed Abstract: 
Subunit-selective proteasome inhibitors are valuable tools to assess the biological and medicinal relevance of individual proteasome active sites. Whereas the inhibitors for the β1c, β1i, β5c, and β5i subunits exploit the differences in the substrate-bin ...